University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

Not Applicable

Terminated

Conditions: Breast Cancer

Interventions: Other: Magnetic Resonance Angiography (MRA) of the Breast

First Posted Date: 2008-03-07

Last Posted Date: 2010-05-18

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 6

Registration Number: NCT00630292

Locations: 🇺🇸
UNC Hospitals, Chapel Hill, North Carolina, United States

Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma

Phase 1

Terminated

Conditions: Mild Allergic Rhinitis
Mild Allergic Rhinitis With Mild Asthma

First Posted Date: 2008-03-07

Last Posted Date: 2012-10-08

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 4

Registration Number: NCT00630461

Locations: 🇺🇸
UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: IFNbeta-1b

First Posted Date: 2008-03-07

Last Posted Date: 2018-10-18

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 56

Registration Number: NCT00630721

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Effect of Gamma Tocopherol Supplementation on Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: gamma tocopherol

First Posted Date: 2008-03-07

Last Posted Date: 2011-04-18

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 18

Registration Number: NCT00631085

Locations: 🇺🇸
University of North Carolina CEMALB, Chapel Hill, North Carolina, United States

IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion

Not Applicable

Completed

Conditions: Ischemic Stroke

Interventions: Drug: IV tpa (Alteplase) vs IA tpa (Alteplase)

First Posted Date: 2008-02-26

Last Posted Date: 2011-11-08

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 7

Registration Number: NCT00624000

Locations: 🇺🇸
University of North Carolina Stroke Center, Chapel Hill, North Carolina, United States

Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating

Not Applicable

Completed

Conditions: Pain

Interventions: Dietary Supplement: Probiotics - Lactobacillus and bifidobacterium
Dietary Supplement: Placebo

First Posted Date: 2008-02-20

Last Posted Date: 2013-07-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 56

Registration Number: NCT00618904

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Proposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm Pilot

Completed

Conditions: IBS, Mixed Symptoms
IBS, Diarrhea Predominant
IBS, Constipation Predominant

Interventions: Other: palm pilot recording responses to questionnaires

First Posted Date: 2008-02-20

Last Posted Date: 2017-06-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 85

Registration Number: NCT00619125

Preventing Falls Through Enhanced Pharmaceutical Care

Not Applicable

Completed

Conditions: Falls

Interventions: Behavioral: Pharmaceutical Care
Other: Written Materials

First Posted Date: 2008-02-20

Last Posted Date: 2011-09-19

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 200

Registration Number: NCT00618800

Locations: 🇺🇸
Injury Prevention Research Center, Chapel Hill, North Carolina, United States

Study of Aripiprazole to Treat Children and Adolescents With Autism

Phase 2

Completed

Conditions: Autistic Disorder
Asperger Syndrome
Autism Spectrum Disorder

Interventions: Drug: aripiprazole

First Posted Date: 2008-02-20

Last Posted Date: 2014-03-26

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 30

Registration Number: NCT00619190

Locations: 🇺🇸
University of North Carolina, Department of Psychiatry, Chapel Hill, North Carolina, United States

Myfortic Conversion Trial in OLT Recipients With GI Intolerance

Completed

Conditions: GI Disturbance

First Posted Date: 2008-02-20

Last Posted Date: 2011-06-03

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 31

Registration Number: NCT00619216

Locations: 🇺🇸
University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy